Detalhe da pesquisa
1.
Combined ligand-based and structure-based design of PDE 9A inhibitors against Alzheimer's disease.
Mol Divers
; 26(5): 2877-2892, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35932437
2.
Rational approaches of drug design for the development of selective estrogen receptor modulators (SERMs), implicated in breast cancer.
Bioorg Chem
; 94: 103380, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31757413
3.
Pharmacophore-based virtual screening, molecular docking and molecular dynamics simulations study for the identification of LIM kinase-1 inhibitors.
J Biomol Struct Dyn
; 41(13): 6089-6103, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-35862656
4.
Identification of potential death-associated protein kinase-1 (DAPK1) inhibitors by an integrated ligand-based and structure-based computational drug design approach.
J Biomol Struct Dyn
; 41(20): 10785-10797, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36576199
5.
Cathepsin B-A Neuronal Death Mediator in Alzheimer's Disease Leading to Neurodegeneration.
Mini Rev Med Chem
; 22(15): 2012-2023, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35156579
6.
A systematic review of carbohydrate-based bioactive molecules for Alzheimer's disease.
Future Med Chem
; 13(19): 1695-1711, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34472382
7.
Estrogen signaling: An emanating therapeutic target for breast cancer treatment.
Eur J Med Chem
; 177: 116-143, 2019 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31129450
8.
Multifunctional hybrid sulfonamides as novel therapeutic agents for Alzheimer's disease.
Future Med Chem
; 11(24): 3161-3178, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31838895
9.
Protein-Protein Interactions and Aggregation Inhibitors in Alzheimer's Disease.
Curr Top Med Chem
; 19(7): 501-533, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30836921
10.
Biomolecular basis of matrix metallo proteinase-9 activity.
Future Med Chem
; 10(9): 1093-1112, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29676173